本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

奧洛茲美醫療

74.93
+1.532.08%
盤後75.000.0700+0.09%17:08 EDT
成交量:189.00萬
成交額:1.40億
市值:87.64億
市盈率:17.16
高:74.96
開:73.67
低:72.39
收:73.40
52周最高:75.46
52周最低:42.01
股本:1.17億
流通股本:1.16億
量比:0.92
換手率:1.63%
股息:- -
股息率:- -
每股收益(TTM):4.37
每股收益(LYR):3.50
淨資產收益率:179.14%
總資產收益率:21.21%
市淨率:26.34
市盈率(LYR):21.40

資料載入中...

2024/07/23

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/07/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/06/28

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/06/28

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/06/26

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/06/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/06/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/05/23

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/05/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/05/08

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/08

重要事件披露

Form 8-K - Current report
2024/04/26

重要事件披露

Form 8-K - Current report
2024/04/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/04/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/29

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/28

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/20

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/20

重要事件披露

Form 8-K - Current report